Research Analysts’ updated eps estimates for Wednesday, October 11th:

Advantage Oil & Gas (NYSE:AAV) (TSE:AAV) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Advantage Oil and Gas Ltd., formerly Advantage Energy Income Fund, is an intermediate oil and natural gas corporation, engaged in the exploration and development of oil and natural gas properties in Alberta and Saskatchewan in Canada. It focuses on developing the Montney natural gas resource play located at Glacier, Alberta. The Company’s properties are located in Alberta and Saskatchewan, and consist of liquids rich natural gas and light oil. The Company’s head office is located in Calgary, Alberta, Canada. “

AllianceBernstein Holding L.P. (NYSE:AB) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ALLIANCE CAP MANAGEMENT L.P. provides diversified investment management services, primarily to pension funds, endowments, foreign financial institutions, and to individual investors. “

Abeona Therapeutics (NASDAQ:ABEO) had its target price raised by Cantor Fitzgerald from $21.00 to $34.00. Cantor Fitzgerald currently has an overweight rating on the stock.

Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “

Aerie Pharmaceuticals (NASDAQ:AERI) was given a $68.00 price target by analysts at JMP Securities. The firm currently has a buy rating on the stock.

AnaptysBio (NASDAQ:ANAB) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California. “

Amira Nature Foods (NYSE:ANFI) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Amira Nature Foods Ltd. provides packaged Indian specialty rice. The Company sells Basmati rice, premium long-grain rice under their flagship Amira brand as well as under other third party brands. It participates across the entire rice supply chain from the procurement of paddy to its storage, aging, processing into rice, packaging, distribution and marketing. Amira Nature Foods Ltd. is headquartered in Dubai, United Arab Emirates. “

Aegean Marine Petroleum Network (NYSE:ANW) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AEGEAN MARINE PETROLEUM is a marine fuel logistics company that physically supplies and markets refined marine fuel and lubricants to ships in port and at sea. They intends to focus on growing its fleet of double hull bunkering tankers and expanding its service centers in strategic locations worldwide to further enhance the Companys extensive customer relationships and leading industry position. “

Abraxas Petroleum Corporation (NASDAQ:AXAS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $2.25 target price on the stock. According to Zacks, “Abraxas Petroleum Corporation is an independent energy company engaged primarily in the acquisition, exploration, exploitation and production of crude oil and natural gas. They seek to complement their acquisition and development activities by selectively participating in exploration projects with experienced industry partners. “

Bank of Hawaii Corporation (NYSE:BOH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bank of Hawaii Corporation is a regional financial services company serving businesses, consumers and governments in Hawaii, American Samoa and the West Pacific. The Company’s principal subsidiary, Bank of Hawaii, was founded in 1897 and is the largest independent financial institution in Hawaii. “

Audentes Therapeutics (NASDAQ:BOLD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Audentes Therapeutics, Inc. is a biotechnology company which focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. The company’s product pipeline consists of AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia and AT982 for the treatment of pompe disease, which are in pre-clinical trial stage. Audentes Therapeutics, Inc. is based in San Francisco, California. “

Baytex Energy Corp (NYSE:BTE) (TSE:BTE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Baytex Energy Trust is a conventional oil and gas income trust focused on maintaining its production and asset base through internal property development and delivering consistent returns to its unitholders. “

B2Gold Corp (NYSE:BTG) (TSE:BTO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $3.25 price target on the stock. According to Zacks, “B2Gold Corp. is involved in the exploration and development of gold. The company’s assets are situated in Nicaragua, Colombia, Namibia and Uruguay. B2Gold Corp. is headquartered in Vancouver, Canada. “

Calix (NYSE:CALX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Calix is a global leader in access innovation. Its Unified Access portfolio of broadband communications access systems and software enables communications service providers worldwide to transform their networks and become the broadband provider of choice to their subscribers. “

Energy Recovery (NASDAQ:ERII) had its buy rating reaffirmed by analysts at FBR & Co.

Fastenal (NASDAQ:FAST) was given a $54.00 target price by analysts at Stephens. The firm currently has a buy rating on the stock.

Global Blood Therapeutics (NASDAQ:GBT) was given a $53.00 target price by analysts at Oppenheimer Holdings, Inc.. The firm currently has a buy rating on the stock.

J P Morgan Chase & Co (NYSE:JPM) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods.

Kronos Worldwide (NYSE:KRO) had its target price increased by SunTrust Banks, Inc. from $21.00 to $24.00. The firm currently has a hold rating on the stock.

Pretium Resources (NYSE:PVG) (TSE:PVG) had its price target raised by Roth Capital from $16.00 to $17.00. They currently have a buy rating on the stock.

Royal Caribbean Cruises (NYSE:RCL) had its price target raised by Argus from $135.00 to $145.00. They currently have a buy rating on the stock.

Smart Global Holdings (NYSE:SGH) had its price target boosted by Roth Capital from $30.00 to $42.00. The firm currently has a buy rating on the stock.

Receive News & Ratings for Advantage Oil & Gas Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advantage Oil & Gas Ltd and related companies with MarketBeat.com's FREE daily email newsletter.